FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
Fasching, Peter A, Jud, Sebastian M, Hauschild, Maik, Kümmel, Sherko, Schütte, Martin, Warm, Matthias, Hanf, Volker, Grab, Dieter, Krocker, Jutta, Stickeler, Elmar, Kreienberg, Rolf, Müller, Thomas, KVolume:
14
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/1471-2407-14-66
Date:
December, 2014
File:
PDF, 251 KB
english, 2014